1. Home
  2. EHTH vs VNDA Comparison

EHTH vs VNDA Comparison

Compare EHTH & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$4.37

Market Cap

128.9M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.77

Market Cap

289.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
VNDA
Founded
1997
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.9M
289.0M
IPO Year
2006
2006

Fundamental Metrics

Financial Performance
Metric
EHTH
VNDA
Price
$4.37
$6.77
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$8.67
$14.00
AVG Volume (30 Days)
353.2K
1.2M
Earning Date
11-05-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$542,951,000.00
$212,074,000.00
Revenue This Year
$4.92
$12.01
Revenue Next Year
$0.24
$21.57
P/E Ratio
$113.51
N/A
Revenue Growth
16.79
11.12
52 Week Low
$3.18
$3.81
52 Week High
$11.36
$7.05

Technical Indicators

Market Signals
Indicator
EHTH
VNDA
Relative Strength Index (RSI) 53.00 66.88
Support Level $4.16 $6.15
Resistance Level $5.35 $7.05
Average True Range (ATR) 0.33 0.45
MACD 0.10 0.09
Stochastic Oscillator 43.65 86.57

Price Performance

Historical Comparison
EHTH
VNDA

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: